These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15172400)

  • 1. Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experience.
    Benza RL; Zoghbi GJ; Tallaj J; Brown R; Kirklin JK; Hubbard M; Rayburn B; Foley B; McGiffin DC; Pinderski LJ; Misra V; Bourge RC
    J Am Coll Cardiol; 2004 Jun; 43(11):1973-81. PubMed ID: 15172400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary interventions with stents in cardiac transplant recipients.
    Bader FM; Kfoury AG; Gilbert EM; Barry WH; Humayun N; Hagan ME; Thomas H; Renlund D
    J Heart Lung Transplant; 2006 Mar; 25(3):298-301. PubMed ID: 16507423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy.
    Simpson L; Lee EK; Hott BJ; Vega DJ; Book WM
    J Heart Lung Transplant; 2005 Sep; 24(9):1211-7. PubMed ID: 16143235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial.
    Garot P; Lefèvre T; Savage M; Louvard Y; Bamlet WR; Willerson JT; Morice MC; Holmes DR
    J Am Coll Cardiol; 2005 Aug; 46(4):606-12. PubMed ID: 16098423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
    Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
    J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).
    Rodriguez AE; Baldi J; Fernández Pereira C; Navia J; Rodriguez Alemparte M; Delacasa A; Vigo F; Vogel D; O'Neill W; Palacios IF;
    J Am Coll Cardiol; 2005 Aug; 46(4):582-8. PubMed ID: 16098419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of percutaneous coronary interventions in early postcoronary artery bypass graft occlusion or stenosis.
    Abdulmalik A; Arabi A; Alroaini A; Rosman H; Lalonde T
    J Interv Cardiol; 2007 Jun; 20(3):204-8. PubMed ID: 17524112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention of bifurcation coronary disease.
    Suzuki N; Angiolillo DJ; Kawaguchi R; Futamatsu H; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Feb; 55(1):57-71. PubMed ID: 17287681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of outcomes of percutaneous coronary intervention on proximal versus non-proximal left anterior descending coronary artery, proximal left circumflex, and proximal right coronary artery: a cross-sectional study.
    Alidoosti M; Salarifar M; Zeinali AM; Kassaian SE; Dehkordi MR
    BMC Cardiovasc Disord; 2007 Mar; 7():7. PubMed ID: 17335586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease.
    van Domburg RT; Lemos PA; Takkenberg JJ; Liu TK; van Herwerden LA; Arampatzis CA; Smits PC; Daemen J; Venema AC; Serruys PW; Bogers AJ
    Eur Heart J; 2005 Apr; 26(7):675-81. PubMed ID: 15637087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-stenosis after drug-eluting stents in cardiac allograft vasculopathy.
    Aqel RA; Wells BJ; Hage FG; Tallaj J; Benza R; Pamboukian S; Rayburn B; McGiffin D; Kirklin J; Bourge R
    J Heart Lung Transplant; 2008 Jun; 27(6):610-5. PubMed ID: 18503959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z; Mahoney EM; Spertus JA; Booth J; Nugara F; Kolm P; Stables RH; Weintraub WS
    Am Heart J; 2006 Dec; 152(6):1153-60. PubMed ID: 17161069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary interventions in patients with transplanted heart coronary artery disease. Effects of intracoronary stent implantation on long-term results.
    Zakliczyński M; Swierad M; Lekston A; Maruszewski M; Zakliczyńska H; Barańska-Kosakowska A; Przybylski R; Kalarus Z; Poloński L; Zembala M
    Kardiol Pol; 2004 Oct; 61(10):339-48; discusion 349. PubMed ID: 15841115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery disease in heart transplant recipients - diagnosis and treatment. Single centre experience based on results of elective coronary angiography.
    Zakliczyński M; Lekston A; Swierad M; Wnek A; Buszman P; Przybylski R; Wojarski J; Przybylski J; Foremny J; Poloński L; Zembala M
    Kardiol Pol; 2003 Feb; 58(2):109-20. PubMed ID: 14504636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison.
    Ijsselmuiden AJ; Ezechiels J; Westendorp IC; Tijssen JG; Kiemeneij F; Slagboom T; van der Wieken R; Tangelder G; Serruys PW; Laarman G
    Am Heart J; 2004 Sep; 148(3):467-74. PubMed ID: 15389234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of fractional flow reserve in patients with multi-vessel coronary artery disease and borderline lesions prevents unnecessary revascularisation procedures.
    Reczuch K; Jankowska E; Telichowski A; Porada A; Banasiak W; Ponikowski P
    Kardiol Pol; 2004 Apr; 60(4):311-19; discussion 320-1. PubMed ID: 15226780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.